© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
Uncovering the unseen and unspoken signs of eosinophilic esophagitis.
March 05, 2021
Exposure to PPIs was associated with a moderate increase in the risk of community-acquired C diff infection, even after treatment discontinuation.
March 04, 2021
Albumin infusions did not result in statistically significant differences in predefined study endpoints.
More patients also achieved endoscopic and histologic remission in the treatment group compared to the placebo group.
February 28, 2021
How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.
Perspective on how the interleukin-targeting biologic has unique benefit for the rare, under-resourced disease.
February 26, 2021
“A high or rising white blood cell count in isolation is not a sufficient indication for C diff infection testing,” the study authors said.
February 25, 2021
The findings should assuage concerns about small intestinal bacterial overgrowth when prescribing treatment with proton pump inhibitors.
Nonanastomotic biliary strictures occurred in 6% of the patients in the machine-perfusion group, while the complication occurred in 18% of the control group.
February 22, 2021
In the U-ACCOMPLISH study, 37% of patients treated with upadacitinib achieved histologic-endoscopic mucosal improvement at week 8.
February 10, 2021
Linaclotide has been marketed as LINZESS to treat irritable bowel syndrome with constipation.